Potential of anticytokine therapies in central nervous system ischaemia

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Central nervous system (CNS) ischaemia is associated with an acute inflammatory response which appears to potentiate CNS injury, especially following reperfusion. This response includes die release of inflammatory mediators called cytokines including IL-1 and TNF-a, which triggers the production of additional cytokines including IL-6 and activates leukocytes which infiltrate into the CNS. Increased expression of cytokines has been demonstrated to occur in the first few hours after CNS ischaemia. Preliminary clinical studies suggest that plasma levels of IL-6 are correlated with functional recovery while brain levels of cytokines have been demonstrated to increase following experimental ischaemia. Although there are no current clinical 'anti-cytokine' treatment studies for stroke, experimental studies modulating IL-1 and TNF-a have shown neuroprotection.

Original languageEnglish (US)
Pages (from-to)227-237
Number of pages11
JournalExpert Opinion on Biological Therapy
Volume1
Issue number2
StatePublished - 2001

Fingerprint

Neurology
Ischemia
Central Nervous System
Cytokines
Interleukin-1
Interleukin-6
Nervous System Trauma
Therapeutics
Reperfusion
Brain
Leukocytes
Stroke
Plasmas
Recovery

Keywords

  • Central nervous system
  • Cytokines
  • IL-6
  • Interleukins
  • Stroke

ASJC Scopus subject areas

  • Pharmacology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Genetics
  • Immunology

Cite this

Potential of anticytokine therapies in central nervous system ischaemia. / Clark, Wayne; Lutsep, Helmi.

In: Expert Opinion on Biological Therapy, Vol. 1, No. 2, 2001, p. 227-237.

Research output: Contribution to journalArticle

@article{80bdb584c11049a6b2cc217eba1b6033,
title = "Potential of anticytokine therapies in central nervous system ischaemia",
abstract = "Central nervous system (CNS) ischaemia is associated with an acute inflammatory response which appears to potentiate CNS injury, especially following reperfusion. This response includes die release of inflammatory mediators called cytokines including IL-1 and TNF-a, which triggers the production of additional cytokines including IL-6 and activates leukocytes which infiltrate into the CNS. Increased expression of cytokines has been demonstrated to occur in the first few hours after CNS ischaemia. Preliminary clinical studies suggest that plasma levels of IL-6 are correlated with functional recovery while brain levels of cytokines have been demonstrated to increase following experimental ischaemia. Although there are no current clinical 'anti-cytokine' treatment studies for stroke, experimental studies modulating IL-1 and TNF-a have shown neuroprotection.",
keywords = "Central nervous system, Cytokines, IL-6, Interleukins, Stroke",
author = "Wayne Clark and Helmi Lutsep",
year = "2001",
language = "English (US)",
volume = "1",
pages = "227--237",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Potential of anticytokine therapies in central nervous system ischaemia

AU - Clark, Wayne

AU - Lutsep, Helmi

PY - 2001

Y1 - 2001

N2 - Central nervous system (CNS) ischaemia is associated with an acute inflammatory response which appears to potentiate CNS injury, especially following reperfusion. This response includes die release of inflammatory mediators called cytokines including IL-1 and TNF-a, which triggers the production of additional cytokines including IL-6 and activates leukocytes which infiltrate into the CNS. Increased expression of cytokines has been demonstrated to occur in the first few hours after CNS ischaemia. Preliminary clinical studies suggest that plasma levels of IL-6 are correlated with functional recovery while brain levels of cytokines have been demonstrated to increase following experimental ischaemia. Although there are no current clinical 'anti-cytokine' treatment studies for stroke, experimental studies modulating IL-1 and TNF-a have shown neuroprotection.

AB - Central nervous system (CNS) ischaemia is associated with an acute inflammatory response which appears to potentiate CNS injury, especially following reperfusion. This response includes die release of inflammatory mediators called cytokines including IL-1 and TNF-a, which triggers the production of additional cytokines including IL-6 and activates leukocytes which infiltrate into the CNS. Increased expression of cytokines has been demonstrated to occur in the first few hours after CNS ischaemia. Preliminary clinical studies suggest that plasma levels of IL-6 are correlated with functional recovery while brain levels of cytokines have been demonstrated to increase following experimental ischaemia. Although there are no current clinical 'anti-cytokine' treatment studies for stroke, experimental studies modulating IL-1 and TNF-a have shown neuroprotection.

KW - Central nervous system

KW - Cytokines

KW - IL-6

KW - Interleukins

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0035294675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035294675&partnerID=8YFLogxK

M3 - Article

C2 - 11727532

AN - SCOPUS:0035294675

VL - 1

SP - 227

EP - 237

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 2

ER -